Topical therapy of diseases of the mucous membrane of the oral cavity, pharynx and larynx of an infectious-inflammatory nature:
The tablet, without chewing, keep in the mouth until completely resorbed.
The total number of tablets per day is 6-8.
Hypersensitivity to the components of the preparation; children under 6 years of age.
Hypersensitivity to the active pharmaceutical ingredient or other ingredients of the preparation.
Probably the development (in isolated cases) of such allergic reactions as Quincke's edema, skin rashes, urticaria, erythema.
The period of application of the preparation should not be 5 days.
1 tablet of Hexalise contains 1.054 g of powdered sugar, this must be taken into account when treating patients with diabetes mellitus or on a carbohydrate-restricted diet.
Due to the presence of sucrose in the preparation, its use is not recommended in patients with fructose intolerance, glucose / galactose malabsorption syndrome or sucrase-isomaltase deficiency.
Perhaps the development of allergic reactions to such an ingredient of the preparation as an orange-yellow dye S (E110).
In case of complaints of severe sore throat or ulceration of the oropharyngeal mucosa, nausea, vomiting, headache, as well as high body temperature, a re-examination of the patient is required, followed by a revision of the therapeutic strategy.
Do not use during pregnancy and lactation.
There was no effect on the reaction rate when driving vehicles or operating other mechanisms.
Due to the likelihood of unwanted interactions, it is necessary to refrain from the combined or sequential use of several topical antiseptic agents.
Information is absent.
At a temperature ≤25 ° C in a place protected from light and out of the reach of children.
There are no reviews for this product.